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Abstract
Normal blood [glucose] regulation is critical to support metabolism, particularly in 
contexts of metabolic stressors (e.g., exercise, high altitude hypoxia). Data regarding 
blood [glucose] regulation in hypoxia are inconclusive. We aimed to characterize 
blood [glucose] over 80 min following glucose ingestion during both normoxia and 
acute normobaric hypoxia. In a randomized cross- over design, on two separate days, 
28 healthy participants (16 females; 21.8 ± 1.6 years; BMI 22.8 ± 2.5 kg/m2) were 
randomly exposed to either NX (room air; fraction of inspired [FI]O2 ~0.21) or HX 
(FIO2 ~0.148) in a normobaric hypoxia chamber. Measured FIO2 and peripheral oxy-
gen saturation were both lower at baseline in hypoxia (p < 0.001), which was main-
tained over 80 min, confirming the hypoxic intervention. Following a 10- min baseline 
(BL) under both conditions, participants consumed a standardized glucose beverage 
(75  g, 296  ml) and blood [glucose] and physiological variables were measured at 
BL intermittently over 80 min. Blood [glucose] was measured from finger capillary 
samples via glucometer. Initial fasted blood [glucose] was not different between trials 
(NX:4.8 ± 0.4 vs. HX:4.9 ± 0.4 mmol/L; p = 0.47). Blood [glucose] was sampled 
every 10 min (absolute, delta, and percent change) following glucose ingestion over 
80 min, and was not different between conditions (p > 0.77). In addition, mean, peak, 
and time- to- peak responses during the 80 min were not different between conditions 
(p > 0.14). There were also no sex differences in these blood [glucose] responses in 
hypoxia. We conclude that glucose regulation is unchanged in young, healthy partici-
pants with exposure to acute steady- state normobaric hypoxia, likely due to counter-
balancing mechanisms underlying blood [glucose] regulation in hypoxia.
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1 |  INTRODUCTION
Blood glucose concentration is tightly regulated through well- 
established mechanisms, which are essential for maintaining 
metabolic homeostasis. Many factors, including carbohy-
drate ingestion, exercise, stress, and environmental condi-
tions may affect glucose regulation in humans (Ahlborg et al., 
1974; Kamba et al., 2016; Larsen et al., 1997). Responses to 
these factors are important for the maintenance of metabolic 
homeostasis, and serious consequences may result following 
significant acute or chronic changes in glucose regulation, 
such as metabolic diseases.
The ingestion of carbohydrates and subsequent absorption 
into the bloodstream results in a temporary rise in blood glu-
cose. Normally, this rise in blood glucose is associated with 
a concomitant rise in insulin, released from pancreatic beta 
cells, lowering blood glucose again via uptake, utilization, 
and/or storage of glucose in tissues (Salunkhe et al., 2016). In 
hypoxic environments, where oxygen availability is reduced, 
there is a shift toward a higher proportion of glucose metabo-
lism (Goto et al., 2015), possibly affecting basal glucose and 
or glucose concentration following carbohydrate ingestion, 
and an increased proportion of glycolytic metabolism and 
fermentation can result in accumulating lactic acid produc-
tion (Lottes et al., 2015).
A number of studies using reduced animal preparations 
suggest the possibility of altered glucose regulation in hy-
poxia, although with conflicting results. Using isolated islets 
of Langerhans beta cells from rats, Ota et al. (2012) found an 
attenuation of insulin secretion following 24 h of intermittent 
hypoxia, which may serve to maintain blood glucose in hy-
poxia in vivo. Conversely, using type II alveolar cells from 
rats, Ouiddir et al. (1999) found that GLUT1 transporters 
were upregulated following 18  h of hypoxic exposure, po-
tentially facilitating an increase in glucose uptake in hypoxia. 
In addition, using dissected hindlimb muscles in rats, Cartee 
et al. (1991) showed an increase in glucose transporter trans-
lation following 40- min perfusion with normocapnic anoxia 
(5% CO2 and 0% O2) perfusate.
Studies in humans investigating the specific effects of hy-
poxia on glucose concentration via interactions with insulin 
release or sensitivity and/or glucose utilization or storage re-
main limited and lack consensus. Many studies suggest that 
blood [glucose] may be  increased in hypoxia, potentially 
through reductions in insulin secretion or sensitivity. Braun 
et al. (2001) found a reduction in insulin sensitivity in 12 
women exposed to simulated 4,300 m for 16 h. Similarly, in 
8  men brought immediately to 4,500  m for 7  days, Larsen 
et al. (1997) found an increase in both blood insulin and 
glucose in the first few days, suggesting the development 
of acute insulin insensitivity. Conversely, a number of stud-
ies suggest that blood [glucose] may be  decreased in hy-
poxia, potentially through an increase in insulin secretion or 
sensitivity or increased glucose utilization. Kelly et al. (2010) 
found no difference in circulating insulin levels and/or a de-
crease in plasma glucose concentration in eight healthy hu-
mans exposed to hypobaric hypoxia equivalent to 4,300  m 
for 120 min. In 12 men exposed to a simulated altitude of 
3,000 m, using tagged glucose and positron emission tomog-
raphy, Chen et al. (2009) found an increase in plasma lactate 
levels and increased glucose uptake in cardiac muscle, but 
not skeletal muscle, brain or liver, suggesting the potential 
for differential mechanisms in glucose homeostasis in be-
tween tissues. In addition, Morishima and Goto (2014) found 
no differences in blood glucose or insulin concentrations in 
eight men exposed to an FIO2 of 14% over 7 h. These stud-
ies suggest that the mechanisms underlying the regulation of 
blood [glucose] may be counterbalanced, leaving [glucose] 
unchanged in hypoxia in humans (Morishima & Goto, 2014).
Given the low number of participants utilized in these 
limited number of previous studies in humans, in addition 
to the disparate findings and current lack of consensus re-
garding the mechanisms and effects of hypoxia on blood 
[glucose], we aimed to characterize the possible interaction 
between acute normobaric hypoxia and [glucose] following a 
standardized oral glucose beverage (75 g glucose in 296 ml) 
in a large number of healthy human participants. Specifically, 
we hypothesized that blood [glucose] over 80 min following 
acute glucose ingestion would not be significantly different 
between acute steady- state normoxia and hypoxia conditions.
2 |  MATERIALS AND METHODS
2.1 | Ethics and participant recruitment
Ethics approval was obtained in advance from the Mount 
Royal University Human Research Ethics Board (Protocol 
2016- 91). This study abided by the Canadian Government 
Tri- Council Policy on Research Ethics Policy Statement 
(TCPS2) and the Declaration of Helsinki, except for registra-
tion in the database. Participants were recruited for the ex-
periment through word of mouth, and participants read and 
signed a consent form which included information on the 
study and risk information, a demographic form, which was 
used to record basic participant information (e.g., weight, 
height, and age) and confirms the lack of self- reported medi-
cal conditions (e.g., respiratory, cardiovascular and meta-
bolic). Participants had a body mass index (BMI) that fell 
within a healthy range of 20– 25 kg/m2, were non- smokers, 
and did not ingest any prescription medications, with the ex-
ception of oral contraceptives. No participants had been to 
altitude in the previous year and were residents of Calgary 
(1,130  m). Biological sex differences were not an a priori 
component of the study design in advance, and the ovarian 
cycle was not accounted for in our female participants.
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2.2 | Equipment and measurements
The Hypoxico Altitude Training System (Hypoxico, Inc.) 
complete with a small portable tent- style chamber and nitro-
gen concentrator was used to simulate hypoxic conditions by 
displacing oxygen within the chamber, increasing the frac-
tion of inspired nitrogen. Two participants at a time were 
seated inside the semi- sealed chamber in chairs, with a small 
table between them for reading material/computers and use 
of portable devices (see below). A portable oxygen analyzer 
(MAXO2ME model R213P65, Maxtec) was used to detect 
and measure the fraction of inspired oxygen (FIO2) inside of 
the tent to ensure accuracy of the targeted level of oxygen 
during each trial. Chamber temperature was measured using 
a digital thermometer inside the chamber (VWR, Traceable 
Digital Thermometer), and recorded manually.
Blood [glucose] measurements were obtained using a 
standard capillary draw using sterile lancets and measured 
with an Accu- Chek Aviva (Roche Diabetes Care) device with 
glucometer sensor strips. Trained investigators utilized cap-
illary samples by asking participants to slip their hand out 
of the tent- style hypoxic chamber (through an open zipper) 
for the ease of capillary sampling by a trained investigator 
positioned outside the chamber, for a total of nine separate 
samples per participant, per trial. After participant training, 
resting heart rate (HR) and peripheral blood oxygen satura-
tion (SpO2) were measured by participants inside the cham-
ber (PureSAT model 7500 pulse oximeter, Nonin Medical, 
Inc.). A single arterial blood pressure value was obtained 
using an automated brachial blood pressure cuff (Omron 
Healthcare), with mean arterial pressure calculated as 2/3 
diastolic +1/3 systolic. In a subset of participants (n = 16), 
steady- state pressure of end- tidal CO2 (PETCO2) was mea-
sured with a portable capnometer (Masimo, EMMA). For 
all measures at all time points, these measures represent a 
single measurement per participant. Participants were mon-
itored through a window in the tent, and instructions were 
relayed to participants as required. For participant safety, par-
ticipants were also provided with sheets with the Lake Louise 
acute mountain sickness (AMS) scoring system (Roach et al., 
1993), and asked to report any acute AMS symptoms to in-
vestigators at each measurement time- point.
2.3 | Experimental protocol
Participants were recruited for a large, within- individual 
cross- over design study to compare the effects of normoxic 
and steady- state hypobaric hypoxia on blood [glucose] over 
80 min. On separate days, separated by at least 2 days, the 
control and experimental protocols were randomized for 
each participant. Participants visited the lab in a fasted state, 
having been instructed to avoid strenuous exercise (e.g., 
Knudsen et al., 2014) and caffeine and food for at least 12 h 
prior to beginning the experiment, which took place before 
noon on the testing day.
2.3.1 | Normoxic conditions
For the hypoxic trial, the nitrogen concentrator was running but 
not connected to the hypoxia tent. This arrangement provided a 
normoxic condition, with the participant breathing room air at 
an altitude of ~1,130 m (PATM O2 ≅ 140 mmHg, FIO2 = 0.209 
of 669 mmHg in Calgary). Each participant was seated inside 
the semi- sealed hypoxia chamber and underwent a 10- min 
baseline measurement, where HR, SpO2, BP, PETCO2, and 
blood [glucose] values were obtained. The participant was 
then allowed up to 5 min to ingest a standard glucose beverage 
(75 g, 296 ml, Trutol). After ingestion, the participant remained 
seated in the hypoxia tent for an additional 80 min, where glu-
cose values were obtained every 10 min between 5 and 10, 15 
and 20, 25 and 30, 35 and 40, 45 and 50, 55 and 60, 65 and 70, 
and 75 and 80- min post- glucose ingestion. FIO2 was monitored 
continuously every 5 min during the 80- min period. SpO2, HR, 
MAP, and PETCO2 values were obtained at 10, 20, 30, 40, 50, 
60, 70, and 80- min post- glucose ingestion.
2.3.2 | Hypoxic conditions
The above protocol was replicated under hypoxic condi-
tions. The nitrogen concentrator was used to achieve the 
hypoxic conditions in the tent, which was monitored and 
equivalent to an altitude of ~4,100 m (PATM O2 ≅ 100 mmHg, 
~FIO2 = 0.148– 0.15 of 669 mmHg in Calgary; ~1,130 m). 
SpO2 was monitored continuously for safety and did not fall 
below 80% in any participant in any trial.
2.4 | Data and statistical analysis
The values obtained from both the control protocol (nor-
moxia) and experimental protocol (hypoxia) are presented as 
mean values  ±  standard deviation (SD). Statistical signifi-
cance was assumed at p < 0.05 Systat SigmaPlot (v. 14).
A paired t test was performed on mean values to compare 
data from the baseline period during both normoxia and hy-
poxia and trials for the following variables: FIO2, SpO2, HR, 
MAP, and fasted blood [glucose] (Table 1).
Two factor repeated- measures ANOVAs (factor one: 
time, factor two: oxygen condition) were performed to as-
sess potential differences in FIO2, SpO2, HR, and MAP for 
each gas trial (i.e., normoxia and hypoxia) to assess potential 
changes in these variables over the protocol duration in each 
trial (Figure 1). Where significant F ratios were detected, a 
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Student– Newman– Keuls post hoc test was utilized for pair- 
wise comparisons.
Two factor repeated- measures ANOVAs (factor one: time, 
factor two: oxygen condition) were performed to assess po-
tential differences in blood [glucose] between normoxic and 
hypoxic conditions. Where significant F ratios were detected, 
a Student– Newman– Keuls post hoc test was utilized for pair- 
wise comparisons. These comparisons were carried out on 
absolute, delta from baseline, and percent change from base-
line measures (Figure 2).
Paired t tests were utilized to compare the 80- min average 
and absolute peak value of blood glucose (wherever it oc-
curred) between hypoxia and normoxia. In addition, a paired 
t test was performed to compare the time- to- peak glucose 
concentration between hypoxia and normoxia (Figure 3).
To assess the potential relationship between SpO2 and 
absolute peak blood [glucose], we performed a Pearson 
product- moment correlation between the peak glucose con-
centration in hypoxic conditions (wherever it occurred) and 
the corresponding SpO2 at that time point.
Last, to assess potential sex differences in [glucose] regu-
lation in hypoxia, we utilized unpaired t tests to assess differ-
ences in mean, peak, and time- to- peak [glucose] in hypoxia 
between males and females.
3 |  RESULTS
3.1 | Baseline values
Twenty- eight participants (16 females; 21.8  ±  1.6  years; 
BMI 22.8  ±  2.5  kg/m2) completed the experiment in both 
randomized, within- individual, cross- over normoxic, and 
hypoxic conditions for a total of 56 trials. Baseline measure-
ments for FIO2, SpO2, HR, MAP, and blood glucose were 
taken for each trial (Table 1). As expected, FIO2 and SpO2 
were significantly lower in hypoxia compared to normoxia 
(p < 0.001), confirming the steady- state hypoxic conditions. 
HR was significantly higher in hypoxia compared to nor-
moxia (p < 0.001), confirming the hypoxic stimulus through-
out. However, MAP and fasted blood [glucose] were not 
significantly different between hypoxic and normoxic trials 
(p = 0.33 and p = 0.47, respectively). Participants did not 
report any AMS symptoms in either trial.
3.2 | Environmental measurements
FIO2 decreased mildly but significantly from 20.4 ± 4.5% to 
19.8 ± 4.5% during the 80- min normoxic trial (p < 0.001) but 
remained stable between 14.8 ± 0.6% and 15.0 ± 0.54% in 
the hypoxic trial (Figure 1a), confirming the hypoxic stimu-
lus throughout. Under normoxic and hypoxic conditions, the 
chamber temperature was significantly higher at 80 min com-
pared to baseline. Under normoxic conditions, the chamber 
temperature increased from 24.6  ±  1.5°C to 26.5  ±  1.5°C 
(p < 0.01), while under hypoxic conditions, the temperature 
increased from 25.4 ± 1.5°C to 27.0 ± 1.5°C (p < 0.01; data 
not shown).
3.3 | Respiratory and cardiovascular 
measurements
Under normoxic conditions, PETCO2 at 80  min was sig-
nificantly higher (36.4 ± 8.9 mmHg) compared to baseline 
(31.8 ± 2.3 mmHg; p = 0.03), confirming a slight accumula-
tion of chamber CO2. Under hypoxic conditions, PETCO2 at 
80 min was not significantly different at 30.8 ± 6.4 mmHg 
compared to normoxia 29.4 ± 4.0 mmHg (p = 0.29), suggest-
ing the airflow from the nitrogen concentrator helped wash 
out metabolically derived CO2 in the chamber (PETCO2 data 
not shown).
SpO2 was significantly higher in normoxic and hypoxic 
conditions throughout 80 min, confirming the hypoxic stim-
ulus throughout (p < 0.001; Figure 1b). Although the SpO2 
was stable across 80 min in the normoxic trial, it did increase 
significantly in the hypoxic condition by 70– 80 min (inter-
action: p = 0.006). HR was higher in hypoxic than normoxic 
conditions throughout 80  min, suggesting a sympathetic 
response to hypoxia (p  <  0.001; Figure 1c). However, HR 
increased significantly under both normoxic and hypoxic 
conditions over 80 min (p < 0.001). There were no differ-
ences in MAP between trials initially (p = 0.7; Figure 1d). 
However, MAP was stable during the normoxic trial, but 
T A B L E  1  Normoxia versus hypoxia intervention and participant 
baseline data recorded at the end of a 10- min baseline in both 
normoxic and hypoxic conditions
Variable/Condition Normoxia Hypoxia
PATM (mmHg) ~669 ~669
FIO2 (%) 20.4 ± 0.4 14.8 ± 0.6
a 
PATM O2 (mmHg) ~140 ~100
PIO2 (mmHg) ~130 ~92
SpO2 (%) 96.8 ± 2.2 88.6 ± 3.7
a 
HR (min−1) 72.0 ± 11.3 79.0 ± 8.9a 
MAP (mmHg) 86.8 ± 8.0 88.2 ± 7.6
Fasted BG (mmol/L) 4.8 ± 0.4 4.9 ± 0.4
Note: PATM, atmospheric pressure in the lab. FIO2, fraction of inspired O2 (%; 
measured). PATM O2, atmospheric O2 pressure (PATM × FIO2). PIO2, pressure 
of inspired O2 ((PATM –  47) × FIO2). SpO2, peripheral oxygen saturation (%; 
measured). HR, heart rate (min−1). MAP, mean arterial pressure (mmHg; 
measured). BG, blood glucose (mmol/L; measured). Values are reported as 
mean ± SD.
aDenotes significant difference from normoxia for that variable (p < 0.001).
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decreased significantly over the duration of the hypoxic trial 
(p = 0.01).
3.4 | Blood [glucose] measurements
Although blood [glucose] increased, peaked, and then de-
creased again over time following oral glucose consumption, 
there were no differences in absolute (interaction: p = 0.77; 
Figure 2a), delta from baseline (interaction: p = 0.94; Figure 
2b) or percent changes in [glucose] (interaction: p = 0.94; 
Figure 2c) between oxygen conditions over the 80 min.
The 80- min average blood [glucose] values for normoxia 
and hypoxia were 7.0 ± 0.6 and 7.3 ±0.8 mmol/L, respec-
tively (p = 0.21; Figure 3a). The absolute peak values (wher-
ever they occurred) for normoxia and hypoxia were 8.8 ± 0.8 
and 9.2 ± 1.1 mmol/L, respectively (p = 0.14; Figure 3b). 
The time- to- peak blood [glucose] for normoxia and hypoxia 
F I G U R E  1  Changes in the fraction of inspired oxygen (FIO2; %), peripheral oxygen saturation (SpO2; %), heart rate (min
−1), and mean 
arterial pressure (MAP; mmHg) in response to varying levels of oxygen over 80 min following glucose ingestion. The data from normoxic 
(black) and hypoxic (grey) conditions collected before (BL; transparent grey box) and after a glucose load. The baseline (BL) measures were 
obtained following 10 min in the chamber in each oxygen condition, but were fasted (transparent grey box). Participants then consumed the 
75 g glucose beverage, under both oxygen conditions (see Figure 2). (a) Mean FIO2 values at baseline were lower in hypoxia (14.8 ± 0.6%) 
compared to normoxia (20.4 ± 0.5%; Table 1), and stable throughout the 80- min protocol. (b) Mean SpO2 values at baseline were lower in 
hypoxia (88.6 ± 3.7%) compared to normoxia (96.8 ± 2.2%; Table 1). SpO2 values were stable throughout the 80- min protocol in normoxia, 
but significantly higher than baseline during the hypoxia protocol. (c) Mean heart rate (HR) values at baseline were higher in hypoxia 
(79.0 ± 8.9 min−1) compared to normoxia (72.0 ± 11.3 min−1; Table 1). HR significantly increased from baseline in both normoxia and hypoxia 
trials. (d) Average MAP values at baseline were not different between hypoxia (88.2 ± 7.6 mmHg) and normoxia (86.8 ± 8.0 mmHg; Table 1). 
MAP values were relatively stable throughout the 80- min protocol in normoxia and hypoxia, but were significantly reduced near the end of the 
hypoxia trial only. All p values for main effects (Time and Condition), and interaction (Time × Condition) indicated on each graph. *represents 
values different from baseline for that (or both) oxygen condition(s) over time. Values are reported as mean ± SD
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were 31.4 ± 9.7 and 31.4 ± 10.1 min, respectively (p = 1.0; 
Figure 3c). Last, there was no correlation between SpO2 and 
peak blood [glucose] under hypoxic conditions (r = 0.013, 
p = 0.95; data not shown).
To address the possibility of sex differences in the [glu-
cose] response in hypoxia, we compared the mean, peak, and 
time- to- peak between males (n = 12) and females (n = 16) 
during hypoxia. We found no differences in mean (p = 0.79), 
peak (p = 0.82) nor time- to- peak (p = 0.92) [glucose] values 
between males and females following glucose ingestion in 
hypoxia.
4 |  DISCUSSION
There are conflicting reports in the literature regarding the 
effects of hypoxia on mechanisms that may affect blood 
[glucose]. Accordingly, we sought to clarify the possible ef-
fect of acute normobaric hypoxia on glucose concentration 
in healthy humans with a larger sample size than previous 
reports. We hypothesized that blood [glucose] would not be 
significantly different between hypoxia and normoxia, as 
there are potential competing mechanisms affecting blood 
glucose regulation. The principal finding of this study is that 
the blood [glucose] response to an acute oral glucose load 
was not different between acute normobaric normoxic and 
hypoxic conditions in young healthy individuals over 80 min.
4.1 | Hypoxia and blood [glucose]
Hypoxic conditions equivalent to altitudes greater than 
4,000  m have been demonstrated to significantly lower 
blood [glucose] compared to normoxia during the first 
60 min following 75 g oral glucose ingestion (n = 8; Kelly 
et al., 2010). Glucose uptake has also been shown to in-
crease to match the metabolic need, decreasing blood [glu-
cose] independent of [insulin] under hypoxic conditions 
Cartee et al., 1991; Chen et al., 2009; Kelly et al., 2010; 
Ouiddir et al., 1999). However, the main finding of this 
F I G U R E  2  Blood [glucose] response at baseline and following a 75 g, 296 ml of standardized glucose beverage under both normoxic (black) 
and hypoxic (grey) conditions. (a) Absolute blood [glucose] values in response to glucose ingestion were not significantly different between 
normoxia and hypoxia. (b) Delta blood [glucose] values in response to glucose ingestion were not significantly different between normoxia and 
hypoxia. (c) Percent change blood [glucose] values in response to glucose ingestion were not significantly different between normoxia and hypoxia. 
All p values for main effects (Time and Condition), and interaction (Time × Condition) indicated on each graph. *represents values different from 
baseline for that (or both) oxygen condition(s) over time. Values are reported as mean ± SD
F I G U R E  3  Average and peak blood [glucose], and time- to- peak [glucose] for all participants in both normoxic (black) and hypoxic (grey) 
conditions. (a) 80- min average blood [glucose] was not significantly different between normoxia and hypoxic conditions (p = 0.21). (b) Absolute 
peak blood [glucose] was not significantly different between normoxia and hypoxic conditions (p = 0.14). (c) Time- to- peak [glucose] (from b) in 
minutes were not significantly different between normoxia and hypoxic conditions (p = 1.0). Values are reported as mean ± SD. NSD, no statistical 
difference
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study, in a large cohort of healthy humans, suggests that 
blood [glucose] remains unchanged in acute steady- state 
hypoxia when compared to normoxia. Conversely, hypoxia 
has also been shown by some studies to have inhibitory ef-
fects on insulin release and sensitivity (Braun et al., 2001; 
Larsen et al., 1997), which could serve to maintain or in-
crease blood [glucose]. One possible mechanism leading to 
the inhibitory effects of hypoxia on both insulin sensitivity 
and secretion is the activation of the sympathetic nervous 
system. Stress hormones such as epinephrine have been 
shown to inhibit insulin- induced glucose uptake, resulting 
in higher blood [glucose] (Chiasson et al., 1981). However, 
Braun et al. (2001) showed that the decrease in insulin 
sensitivity under hypoxic conditions was not epinephrine- 
mediated. Cortisol, another stress hormone released upon 
exposure to hypoxia, is associated with a decrease in in-
sulin secretion, possibly leading to higher blood [glucose] 
(Kamba et al., 2016). Thus, the overall lack of difference 
in blood [glucose] between conditions in our study may 
be explained in part due to the counterbalancing action of 
an increase in glucose uptake in non- insulin- dependent 
tissues (e.g., Watson & Pessin, 2001) or glucose utiliza-
tion by somatic cells, and reduced insulin secretion and/
or sensitivity, serving to maintain blood [glucose]. In ad-
dition, a study by Morishima and Goto (2014) showed (a) 
an increase in metabolic rate but (b) no significant differ-
ences in blood [glucose] over 7 h at a moderate simulated 
altitude (15% FIO2) following the ingestion of a 75 g oral 
glucose load, similar to the present study, although with a 
much lower number of participants (n = 8; Morishima & 
Goto, 2014).
4.2 | Sympathetic response to acute hypoxia
The increase in HR observed over 80 min in the hypoxic trial 
is likely a response to the hypoxic stressor, although there 
was also an initial increase in HR in the normoxic trial. A 
possible explanation for these results is the activation of the 
sympathetic nervous system in response to the glucose inges-
tion itself (Smorschok et al., 2018; Synowski et al., 2013). 
Hypoxia is known to stimulate the peripheral chemorecep-
tors to elicit a sympathetic chemoreflex, which leads to an 
increase in HR and vascular resistance (i.e., vasoconstriction; 
Steinback et al., 2009). An increase in temperature has also 
been shown to increase sympathetic activation, leading to an 
increase in HR (Madaniyazi et al., 2016), as does glucose 
ingestion, which was recently shown to activate the sympa-
thetic nervous system (Smorschok et al., 2018), leading to an 
increase in the heart rate (Synowski et al., 2013). However, 
MAP was significantly lower after 80  min in the hypoxic 
trial. This is likely due to hypoxia- induced vasodilation 
(Blitzer et al., 1996). Accordingly, the vasodilatory effect of 
hypoxia is likely greater than its effects on sympathetic acti-
vation, lowering MAP over time.
4.3 | Methodological considerations
The present study exposed participants to a normobaric hy-
poxic stimulus equivalent to a simulated altitude of ~4,100 m 
(PATM O2 ≅ 100  mmHg, ~FIO2  =  0.15 of 669  mmHg in 
Calgary; ~1,130 m) for only 80 min, shorter than a typical 
clinical oral glucose tolerance test (OGTT) protocol of 2 h. 
However, we do not believe that a longer duration would 
have had a significant effect on these responses, in part 
because participants were long past their peak blood [glu-
cose] (occurring early at ~30 min), and Morishima and Goto 
(2014) demonstrated that there were no significant changes 
in glucose regulation after being exposed to hypoxia for 7 h. 
However, available evidence on glucose uptake by tissues 
is inconclusive regarding time course (e.g., Gamboa et al., 
2011; Heinonen et al., 2011), and thus more studies are nec-
essary in order for definite conclusions to be drawn regarding 
potential oxygen and blood [glucose] interactions. We aimed 
to assess the mean and peak blood [glucose] responses to 
acute hypoxia in healthy men and women, not assess the lon-
gitudinal responses in a clinical diabetic population, where 
the end- point at 120- min OGTT are utilized. Accordingly, 
we believe our protocol comparing normoxic and hypoxic 
peak and mean responses over 80 min in a large number of 
healthy participants addressed our experimental question on 
the effects of acute hypoxia on short- term control of blood 
[glucose].
One limitation of this study was the lack of additional 
measurements of associated humoral variables. Lactate, in-
sulin, and stress hormones (e.g., epinephrine and cortisol) 
were not measured, as we chose to trade off study complexity 
in favor of large participant recruitment. The measurement of 
plasma insulin may have confirmed the inhibitory effects of 
hypoxia on insulin secretion, and the measurements of stress 
hormones could suggest a mechanism resulting in an inhibi-
tory effect on insulin secretion. Because of these limitations, 
we can only speculate as to the underlying mechanisms re-
sponsible for our observations, where blood [glucose] was 
unchanged between conditions. However, we believe that the 
high sample size and multiple methods of analysis (i.e., ab-
solute, delta, percent, mean, peak, and time- to- peak) in our 
study add confidence to our conclusion that blood [glucose] 
homeostasis, and likely insulin release or sensitivity, is un-
changed in healthy humans exposed to acute steady- state nor-
mobaric hypoxia.
Our participants visited the lab fasted, having avoided 
strenuous exercise (Knudsen et al., 2014), caffeine, and food 
for at least 12- h prior to visiting the lab on the morning of 
the testing day. However, we did not instruct participants 
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regarding standardizing diet the night before. Robertson et al. 
(2002) demonstrated that the effects of high- fat and high- 
carbohydrate evening meals can persist overnight, affecting 
the blood [glucose] responses to an OGTT. However, they 
did not detect any effects on morning glucose or insulin con-
centrations. Although we acknowledge this weakness in our 
design, we did not observe any differences in blood [glucose] 
between groups under baseline conditions, and the large 
within- participant likely minimizes any effects of high fat or 
high carbohydrate meals the day before our study.
The Accu- Chek Aviva point- of- care device used in the 
present study utilizes the glucose- 1- dehydrogenase method 
of measuring blood [glucose]. This method differs from sim-
ilar studies that use laboratory determinations of blood [glu-
cose] with the glucose oxidase method (Kelly et al., 2010; 
Morishima & Goto, 2014). However, given that our study was 
being conducted under hypoxic conditions, using a method 
other than the glucose oxidase method may be a strength of 
our study (see Tonyushkina & Nichols, 2009). Nonetheless, 
the Accu- Chek Aviva has been assessed to be an accurate 
method of measuring blood [glucose] (Tack et al., 2012), and 
likely did not result in relevant inaccuracies. In addition, par-
ticipants acted as their own controls, and we tracked changes 
over time, within- individuals.
The small normobaric chamber used in the protocol also 
presents a limitation. The small decrease in FIO2 observed 
across the 80- min normoxic trial is most likely due to the met-
abolic rate of the participants, utilizing the available ambient 
O2 and accumulating metabolically- derived CO2 in the small 
chamber without air circulation. In addition, the small size of 
the normobaric chamber led to an accumulation of CO2 as well 
as an increase in temperature inside of the chamber. Both of 
these consequences likely contributed to the increases in sym-
pathetic nervous system activation independent of the hypoxia, 
as evidenced by the increase in HR over 80 min. The accu-
mulation of CO2 was assessed through the measurement of 
PETCO2, which was mildly but significantly higher over 80 min 
compared to baseline in the normoxic trial. The accumulation 
of the CO2 in the chamber likely augmented the hypoxic ven-
tilatory response (e.g., Teppema & Dahan, 2010), which could 
increase the relative SpO2 for the participants over 80  min. 
Moreover, in the hypoxic trial, the continuous airflow from 
the nitrogen concentrator likely eliminating some of the accu-
mulating CO2, as it was replacing the chamber air. Therefore, 
the PETCO2 at 80 min in the hypoxic trial was not significantly 
different compared to the baseline. The small increase in SpO2 
observed in the hypoxic trial over 80 min was likely due to a 
hypoxic ventilatory response, in which the participants were 
responding to the lower amount of O2 in the normobaric hy-
poxia chamber (Teppema & Dahan, 2010). However, there 
was a small but a significant rise in SpO2 in the normoxic 
trial suggesting that the accumulating CO2, and possibly the 
increase in ambient temperature, increased ventilation in the 
normoxic trial (Tsuji et al., 2019). Last, the small increase in 
temperature could also result in peripheral vasodilation, which 
could contribute to the slight decrease of MAP over the 80 min 
in hypoxia. Thus, small normobaric hypoxia chambers come 
with a number of caveats that should be considered in experi-
mental design and interpretation of results.
4.4 | Potential significance
There is considerable controversy as to whether or not hy-
poxia elicits a change in the regulation of blood [glucose]. 
Therefore, the rationale of this study was to clarify the po-
tential interactions between acute normobaric hypoxia and 
blood [glucose] in a large number of healthy, unacclimatized 
lowlanders. According to our results, the time course and 
magnitude of the changes in blood [glucose] in response to a 
standard oral glucose load in young healthy individuals are not 
different during acute exposure to steady- state hypoxia. This 
information could be of interest for trekkers ascending to high 
altitude, as it may provide insightful information regarding 
nutritional requirements in chronic hypoxia, particularly with 
superimposed exercise, where metabolic demand is increased. 
Trekkers ascending and residing at high altitude may have to 
adjust their carbohydrate intake to meet their metabolic needs, 
but the extent of this requirement remains unknown.
There are also disparate findings with respect to diabetic 
populations at altitude. Previous studies have demonstrated 
that sustained hypoxia lowers blood [glucose] through increas-
ing glucose utilization, which could be beneficial for people 
with diabetes (e.g., Kelly et al., 2010). A study performed by 
Duennwald et al. (2013) found that the exposure to intermittent 
hypoxia (IH) over 1 h resulted in a reduction in blood [glu-
cose], suggesting a potential benefit of IH to diabetic patients. 
However, hypoxia may also decrease insulin sensitivity (Larsen 
et al., 1997) and possibly exacerbate the danger of uncontrolled 
diabetes. In addition, a previous study demonstrated that hy-
poxia increased blood [glucose] (Singh et al., 2014), possibly 
through decreasing insulin production or sensitivity, which 
may also exacerbate the negative effects of uncontrolled dia-
betes (i.e., hyperglycemia). In a study performed by Vera- Cruz 
et al. (2015) using hyperbaric oxygen therapy (i.e., exposure 
to high PO2), fasted plasma [glucose] and glucose tolerance 
to an OGTT was improved in diabetic patients, suggesting an 
oxygen- dependent effect on blood [glucose] regulation in pa-
tients with diabetes. Interestingly, with respect to high altitude 
natives, Okumiya et al. (2016) found that highland natives in 
Tibet living at altitudes above 3,500 m were more susceptible 
to the development of glucose intolerance and diabetes, but this 
result likely has a number of lifestyles (e.g., physical activity, 
diet) factors contributing to it. These disparate results depend 
upon the degree and mode of hypoxia, as well as the popula-
tion of interest. Thus, there is a critical need for more research 
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toward understanding the potential interaction between oxygen 
status and blood glucose regulation, particularly regarding the 
differential patterns (e.g., intermittent, acute, sustained) and 
magnitude of hypoxia, and the differential rates of diabetes in 
highlander versus low lander populations (e.g., Koufakis et al., 
2019; Woolcott et al., 2015).
5 |  CONCLUSIONS
In conclusion, in a large sample of young healthy male 
and female participants, blood [glucose] in response to 
standard oral glucose ingestion (75  g, 296  ml) was un-
changed during exposure to acute steady- state normobaric 
hypoxia (FIO2 ~14.8%) compared to room air over 80 min, 
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